What is the Hyperion DeFi, Inc. stock price forecast?

Hyperion DeFi, Inc. is currently trading at $3.24. View real-time AI analysis on Alpha Lenz.

What is Hyperion DeFi, Inc. insider trading activity?

View the latest insider trading data for Hyperion DeFi, Inc. on Alpha Lenz.

What is Hyperion DeFi, Inc.'s P/E ratio?

View Hyperion DeFi, Inc.'s valuation metrics on Alpha Lenz.

Hyperion DeFi, Inc.

NASDAQ · HYPD

$3.24+0.32(+10.96%)Pre-market

Ask about Hyperion DeFi, Inc.'s future dividend policy...

Alpha Chat Insight

“Hyperion DeFi, Inc.'s ROE is -324.1%. Explore profitability and growth together.”

Ask for details →

Company Overview

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.

CEOMr. Hyunsu Jung

Websitehttps://hyperiondefi.com

SectorHealthcare

IndustryBiotechnology

Employees13

Company Statistics

FY 2025

Profile

N/AMarket Cap

$813.46KRevenue

0.00Shares Out

13Employees

Margins

62.72%Gross

-2256.01%EBITDA

-2333.42%Operating

-5570.61%Pre-Tax

-5570.61%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-163.50%ROA

-324.08%ROE

-157.88%ROIC

Financial Health

$6.44MCash & Cash Equivalents

$4.26MNet Debt

26.07%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Hyperion DeFi, Inc.'s ROE is -324.1%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Hyperion DeFi, Inc. (ticker: HYPD) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 13 employees.

The current price is $3.24 with a P/E ratio of -x and P/B of -x.

ROE is -324.08% and operating margin is -2333.42%. Annual revenue is $813,455.